CSS LLC’s Aegerion Pharmaceuticals AEGR Stock Holding History

CSS LLC’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$30K	–	830
2016 Q3	$30K	Hold	10,000	–	–	﹤0.01%	691
2016 Q2	$15K	Sell	10,000 -10,500	-51%	-$24K	﹤0.01%	684
2016 Q1	$76K	Sell	20,500 -35,600	-63%	-$220K	﹤0.01%	609
2015 Q4	$566K	Buy	56,100 +24,400	+77%	+$294K	0.03%	332
2015 Q3	$431K	Sell	31,700 -60,000	-65%	-$1.07M	0.03%	425
2015 Q2	$1.74M	Buy	+91,700	New	+$1.98M	0.08%	223

CSS LLC's AEGR Position: Q3 2015 in Review

CSS LLC sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2015, closing a stake of 32,532 shares — an estimated $579K sold.

CSS LLC first reported a position in AEGR in Q2 2015 and held it in 1 quarter. The position peaked at $617K in Q2 2015. 96 funds tracked by Wall St. Rank hold AEGR as of Q3 2015.

CSS LLC reported no remaining Aegerion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
CSS LLC sold 32,532 Aegerion Pharmaceuticals shares in Q3 2015, an estimated $579K.
CSS LLC first reported a position in Aegerion Pharmaceuticals in Q2 2015 and held it in 1 quarter.
CSS LLC's Aegerion Pharmaceuticals position peaked at $617K in Q2 2015.
96 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2015.

Based on CSS LLC's 13F filing for Q3 2015, filed 16 Nov 2015.